CROI 2014: Advances in antiretroviral therapy

Barbara S. Taylor, Noga Shalev, Timothy J. Wilkin

Research output: Contribution to journalConference articlepeer-review

1 Scopus citations


The 2014 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted important advances in antiretroviral therapy, with an emphasis on HIV eradication strategies. Follow-up information about the Mississippi baby who remains free of HIV infection off antiretroviral therapy was presented, and a second baby and 1 adult may also have been cured with very early initiation of antiretroviral therapy. The HIV care cascade was again a major focus of the conference. Investigators from around the world presented data on the implementation, and limitations, of the care cascade paradigm. Scale-up of antiretroviral therapy continues and a number of presentations featured optimal ways to measure the impact of these efforts by applying lessons from implementation science and health care economics. Encouraging results from expanded prevention of mother-to-child transmission programs, especially Option B+, were highlighted. Extensive data on transmitted (primary) drug resistance in the United States and Europe were presented.

Original languageEnglish (US)
Pages (from-to)616-631
Number of pages16
JournalTopics in Antiviral Medicine
Issue number2
StatePublished - Jan 1 2014
EventAnnual Conference on Retroviruses and Opportunistic Infections, CROI 2014 - Boston, MA, United States
Duration: Mar 3 2014Mar 6 2014


  • CROI 2014
  • Cascade of care
  • Cure
  • HIV
  • Resource limited
  • Treatment

ASJC Scopus subject areas

  • Pharmacology
  • Virology
  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'CROI 2014: Advances in antiretroviral therapy'. Together they form a unique fingerprint.

Cite this